Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Acronyms ellipse II
- Sponsors HRA Pharma
- 18 Sep 2014 One of the brands of study drug Ulipristal (ella one) deleted from protocol and trial title got changed, study status got changed from discontinued to recruiting, number of pt. got changed from 500 to 100, trial locations changed to only USA and Centers.
- 22 Jan 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 13 Apr 2012 New trial record